The Hill: Competition, Not Capping Increases, is the Cure for High Drug Prices

Soaring prescription drug prices are putting financial pressure on families across the country. In response, state legislators are increasingly considering limits on the annual price increase of prescription drugs. But rather than making drugs more affordable, these policies risk reducing consumer access to cheaper, generic alternatives.

Read this op-ed in The Hill

 

 

 

 

FacebooktwitterredditlinkedinFacebooktwitterredditlinkedin